Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06521502 · ClinicalTrials.gov registry record
The APS Phenotyping Study
A clinical trial of Sepsis and Pneumonia, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 20
- Study locations
NCT06521502: Recruiting study of Sepsis and Pneumonia, sponsored by Vanderbilt University Medical Center.
NCT06521502 is a study of Sepsis and Pneumonia that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 4,000 participants, below the 6,520-participant average among 90 other Sepsis trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06521502, a study of Sepsis and Pneumonia, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will be available to investigators for future studies of ARDS, sepsis, and/or pneumonia.
Primary Outcome
Classification of critically ill adults into disease categories based on published paradigms, including the Berlin Criteria for ARDS, Sepsis-3 criteria for sepsis, and Centers for Disease Control and Prevention (CDC) criteria for pneumonia.
Interventions
- OTHER Blood collection
- OTHER Urine Collection
- OTHER Nasal, oral, and rectal swabs
- OTHER Stool collection
- OTHER Heat Moisture Exchange Filter collection
Study Locations (20)
California
- Fresno Community Hospital and Medical Center - Fresno
- Stanford University - Palo Alto
- San Francisco General Hospital - San Francisco
- University of California, San Francisco - San Francisco
Colorado
- University of Colorado, Denver - Denver
- Denver Health and Hospital Authority - Denver
- National Jewish Health - Denver
- UC Health Medical Center of the Rockies - Loveland
Illinois
- Northwestern Memorial Hospital - Chicago
- University of Chicago - Chicago
Tennessee
- Meharry Medical College - Nashville
- Vanderbilt University Medical Center - Nashville
Utah
- Intermountain Medical Center - Murray
- University of Utah - Salt Lake City
Maryland
- Johns Hopkins Univeristy - Baltimore
Michigan
- University of Michigan - Ann Arbor
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2024-07-25 |
| Est. Completion | 2029-04-30 |
What NCT06521502 shows while recruiting
NCT06521502 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, below the 6,520-participant average among 90 other Sepsis trials with a reported enrollment target (39% lower).
The record links to 3 conditions, with Sepsis appearing as the primary indexed condition, and to 5 interventions - of which Blood collection is the first listed.
NCT06521502 names 20 study sites across 11 states, led by California, Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT06521502 about?
NCT06521502 is a clinical study titled "The APS Phenotyping Study". The goal of the observational APS phenotyping study is to better understand risk factors, potential biomarkers, length and severity of illness, and recovery for adults with ARDS, pneumonia, and/ or sepsis. This study will also generate a biobank of specimens collected from these patients that will b...
What is the current status of trial NCT06521502?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2024-07-25. Estimated completion is 2029-04-30.
What conditions does trial NCT06521502 study?
This clinical trial studies the following conditions: Sepsis, Pneumonia, ARDS.
What interventions are being tested in trial NCT06521502?
The interventions under investigation include: Blood collection (OTHER), Urine Collection (OTHER), Nasal, oral, and rectal swabs (OTHER), Stool collection (OTHER), Heat Moisture Exchange Filter collection (OTHER).
Who is sponsoring clinical trial NCT06521502?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06521502 being conducted?
This trial has 20 study locations across California, Colorado, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sepsis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06521502's enrollment target sits among peer trials
4,000 11th of 90 higher than 80 of 90 other Sepsis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sepsis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
RECRUITING · Phase 2
-
Early Versus Late Adjunctive Vasopressin in Septic Shock
RECRUITING · Phase 4
-
Renin Angiotensin Aldosterone System In Septic Kids
RECRUITING
-
The RightCall: Implementing a Sepsis Diagnostic Toolkit to Improve Pediatric Diagnosis in ED Transfer Calls
RECRUITING · NA
-
External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients
RECRUITING · NA
-
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00227253 · 4,000 participants
Chromosome 18 Clinical Research Center
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI